Berberine, the main bioactive component of Coptis chinensis Franch., is widely used in the
treatment of diabetes. Previous studies have reported that berberine supplementation may …

Background: Memory-impairment was one of the common characteristics in patients with
diabetes mellitus. The release of chronic inflammation mediators and insulin resistance in …

Diabetic cognitive impairment is a common complication in type 2 diabetes. Berberine (BBR)
is an isoquinoline alkaloid that has been shown to have neuroprotective effects against …

Background: Cognitive impairment caused by diabetes has been recognized. Berberine is
well known for its resistance to peripheral lesions, but it is rarely used for the treatment of …

Background A growing number of epidemiological studies indicate that metabolic syndrome
(MetS) and its associated features play a key role in the development of certain …

The cognitive dysfunction caused by prediabetes causes great difficulties in human life, and
the terrible thing is that the means to prevent the occurrence of this disease are very limited …

Background and aim Diabetes-associated cognitive impairment (DCI) is a prevalent
complication of diabetes. However, there is a lack of viable strategies for preventing and …

Diabetes is a group of metabolic disorders with an increased risk of developing cognitive
impairment and dementia. The hippocampus in the forebrain contains an abundance of …

Cognitive impairment is a well-known complication of Type 2 diabetes mellitus (T2DM)
characterized by cellular insulin resistance, chronic inflammation, and metabolic …

The association between diabetes and dementia has been well demonstrated by
epidemiologic studies. Berberine (BBR) has been reported to ameliorate diabetes and …